Renalytix Laboratories
About Renalytix Laboratories
All KidneyIntelX tests are performed by Renalytix Labs at one of its state-of-the-art, CLIA (Clinical Laboratory Improvement Amendments) registered clinical laboratories.
Renalytix Labs New York
101 6th Avenue, 3rd FL
New York, NY 10013
Renalytix Labs Utah
421 Wakara Way, Suite 309,
Salt Lake City, UT 84108
Renalytix Labs Leadership

Michael Donovan Ph.D., M.D. joined Renalytix, Inc in 2018 and serves as the Chief Medical Officer. Dr. Donovan is board-certified in anatomic and clinical pathology and pediatric pathology with extensive experience in designing and implementing clinical studies. He has spearheaded the utilization of multiplex tissue and fluid–based assays and coupled mathematical applications to produce clinically relevant diagnostic/predictive/prognostic outcome models for a variety of tumor types and disease states. Along with his clinical duties, Dr. Donovan also serves as a Professor of Experimental Pathology and Director of the Biorepository and Pathology core at the Icahn School of Medicine at Mt. Sinai, New York City, New York.
In addition to an academic career at Harvard Medical School and Boston Children’s Hospital, Dr. Donovan has over 20 years’ experience in the biotechnology industry, serving in various senior management roles at Millennium Pharmaceuticals and Incyte Pharmaceuticals. He most recently served as Chief Medical Officer of Aureon Biosciences, Inc, Chief Medical Officer of MetaStat, Inc., Chief Medical Officer of Exosome Diagnostics, Inc. where he was a laboratory and medical director responsible for clinical assay development, validation and implementation as well as overseeing the execution of several clinical trials and authored multiple publications. He was also the Chief Medical Officer of Vigilant Biosciences where he was responsible for the development and monitoring of multiple European trials and a multi-site FDA study.
Dr. Donovan earned a B.S. in Zoology from Rutgers University, a Master of Science in Endocrinology and a Ph.D. in Cell and Developmental Biology with Post–Doctoral studies at Harvard Medical School. After completing his Pediatric Fellowship at Children’s Hospital, he transitioned to an Assistant Professor in the department of pathology at Harvard Medical School. He earned his M.D. from the University of Medicine and Dentistry of New Jersey.

Baljit (BJ) Singh is Head of Clinical Laboratory Operations for Renalytix. He is responsible for all clinical lab operations activities across the company.
Prior to joining Renalytix in February 2020, Mr. Singh held various leadership roles at Quest Diagnostics, a worldwide provider of IVD diagnostics, where he helped accelerate growth and led various laboratories. Before joining Quest Diagnostics, he held science and technical operations roles with ARUP Laboratories and Labcorp.
Mr. Singh received an MBA from University of Utah’s David Eccles School of Business and a bachelor’s degree in Clinical Lab Science from the University of Nebraska Medical Center. He is certified in Six Sigma methodologies. He is fluent in Hindi, Punjabi and loves to be outdoors.
Certificates and Credentials
Access Renalytix’s licensing, required state certifications and accreditations.
Salt Lake City Lab
CLIA
46D2176492
View Certificate >
California License
State ID: C0S-90001569
View License >
CAP Accreditation
9068095
View License >
ISO 13485 Certificate
US20/819943959
View Certificate >
ISO/IEC 27001:2013 Certificate
US21/819944357.00
View Certificate >
Maryland Permit
3305
View Permit >
Pennsylvania Permit
39074
View Permit >
Rhode Island License
LCO01367
View License >
New York Lab
CLIA
33D2156875
PFI Number: 9398
View Permit >
California License
State ID: C0S-90004389
View License >
ISO/IEC 27001:2013 Certificate
US21/819944357.00
View Certificate >
Maryland Permit
3148
View Permit >
Pennsylvania Permit
37610
View Permit >
Rhode Island License
LCO01384
View License >